Q4 2023 · 13F-HR
Blue Water Life Science Advisors, LPholdings as filed
Filed 2024-02-14 · accession 0001172661-24-001487
$114.2M
Reported value
9
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 632307104 | NTRA | NATERA INC | $24.9M | 21.8% | 397,436 | Common | SOLE |
| 00974H104 | — | AKOYA BIOSCIENCES INC | $22.9M | 20.1% | 4,697,785 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $15.4M | 13.5% | 571,047 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $13.7M | 12.0% | 25,800 | Common | SOLE |
| 88025U109 | TXG | 10X GENOMICS INC | $10.9M | 9.53% | 194,500 | Common | SOLE |
| 57777K106 | MXCT | MAXCYTE INC | $8.9M | 7.76% | 1,885,000 | Common | SOLE |
| 00650F109 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $8.3M | 7.24% | 1,687,665 | Common | SOLE |
| 74766Q101 | QTRX | QUANTERIX CORP | $7.9M | 6.90% | 288,196 | Common | SOLE |
| 63009R109 | NSTGEUR | NANOSTRING TECHNOLOGIES INC | $1.3M | 1.15% | 1,751,891 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.